News

CANDEL THERAPEUTICS LEASES 16,000SF OF LAB/OFFICE AT 117 KENDRICK STREET IN NEEDHAM, MA

Bulfinch announced today that Candel Therapeutics, a Massachusetts based biotechnology company, has signed a 7-year lease for 16,000 SF of lab and office space at 117 Kendrick Street in Needham, MA. Mike Wilcox, SVP, Director of Leasing at…
Read the Story

Bulfinch Breaks Ground on 270,000 SF State-Of-The-Art Lab and Office Building at Cambridge Discovery Park

Bulfinch announced today that construction is underway at 400-500 Cambridge Discovery Park, a new world class 270,000-square-foot Class A lab, R&D and office development at Cambridge Discovery Park (CDP). The six-story building with two separate bases and a…
Read the Story

Bulfinch Strengthens Portfolio with the Acquisition of 10 Brookline Place

Bulfinch, a private real estate investment, development and management firm, today announced that an affiliate of the company has completed the acquisition of 10 Brookline Place in Brookline, MA. The property consists of six floors and totals approximately…
Read the Story

Bulfinch Closes Long Term Non-Recourse Loan Secured by New Chardon Street Property

Bulfinch, a private real estate investment, development and management firm, today announced that it closed on a long-term non-recourse loan secured by The Atlantic Charter Building with Lincoln National Life Insurance Company. The 15-year loan carries an attractive…
Read the Story

Bulfinch Promotes Conor Brennan To Senior Vice President, Acquisitions

Bulfinch, a private real estate investment, development and management firm, today announced the appointment of Conor Brennan to Senior Vice President, Acquisitions. Conor heads Bulfinch’s acquisitions team focusing on continued growth of the Bulfinch portfolio by sourcing, analyzing…
Read the Story

Bulfinch Promotes Mark R. Diorio To Managing Director And General Counsel

Bulfinch, a private real estate investment, development and management firm, today announced the appointment of Mark R. DiOrio to the expanded role of Managing Director and General Counsel. Mark joined Bulfinch in 1997 after nearly a decade practicing…
Read the Story
1 2 3